Microbix J (MBX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 456 | 472 | 445 | 428 | 435 |
| Accounts receivable | -2,374 | 784 | 119 | 2,434 | -759 |
| Other Working Capital | -2,213 | 816 | -1,021 | 242 | -795 |
| Other Operating Activity | 1,528 | -1,987 | -1,467 | -2,137 | 1,912 |
| Operating Cash Flow | $-2,602 | $84 | $-1,924 | $967 | $793 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -170 | -154 | -195 | -245 | -203 |
| Investing Cash Flow | $-170 | $-154 | $-195 | $-245 | $-203 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -69 | -69 | -53 | -1,223 | -73 |
| Common Stock Repurchased | -174 | -208 | -267 | -744 | -511 |
| Other Financing Activity | 0 | 359 | 0 | 2,737 | 80 |
| Financing Cash Flow | $-242 | $82 | $-320 | $769 | $-505 |
| Beginning Cash Position | 12,113 | 12,101 | 14,539 | 13,048 | 12,963 |
| End Cash Position | 9,098 | 12,113 | 12,101 | 14,539 | 13,048 |
| Net Cash Flow | $-3,015 | $12 | $-2,438 | $1,491 | $85 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,602 | 84 | -1,924 | 967 | 793 |
| Capital Expenditure | -170 | -154 | -195 | -245 | -203 |
| Free Cash Flow | -2,773 | -70 | -2,118 | 721 | 590 |